These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2125989

  • 1. Detection of proteins that recognize platinum-modified DNA using gel mobility shift assay.
    Fujiwara Y, Kasahara K, Sugimoto Y, Nishio K, Ohmori T, Saijo N.
    Jpn J Cancer Res; 1990 Dec; 81(12):1210-3. PubMed ID: 2125989
    [Abstract] [Full Text] [Related]

  • 2. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-DNA damage recognition proteins in human tumour extracts.
    Bissett D, McLaughlin K, Kelland LR, Brown R.
    Br J Cancer; 1993 Apr 15; 67(4):742-8. PubMed ID: 8471431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Binding of the Escherichia coli UvrAB proteins to the DNA mono- and diadducts of cis-[N-2-amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II ) and cisplatin. Analysis of the factors controlling recognition and proof of monoadduct-mediated UvrB-DNA cross-linking.
    Lambert B, Jestin JL, Bréhin P, Oleykowski C, Yeung AT, Mailliet P, Prétot C, Le Pecq JB, Jacquemin-Sablon A, Chottard JC.
    J Biol Chem; 1995 Sep 08; 270(36):21251-7. PubMed ID: 7673159
    [Abstract] [Full Text] [Related]

  • 6. Binding kinetics of tetrachloro-1,2-diaminocyclohexaneplatinum (IV) (tetraplatin) and cis-diamminedichloroplatinum (II) at 37 degrees C with human plasma proteins and with bovine serum albumin. Does aquation precede protein binding?
    LeRoy AF, Thompson WC.
    J Natl Cancer Inst; 1989 Mar 15; 81(6):427-36. PubMed ID: 2918550
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM, Dijkman R, Begg AC, Dubbelman R, Floot BG, Hart AA, den Engelse L.
    Cancer Res; 1988 Oct 01; 48(19):5597-603. PubMed ID: 3046743
    [Abstract] [Full Text] [Related]

  • 8. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
    Marples B, Adomat H, Billings PC, Farrell NP, Koch CJ, Skov KA.
    Anticancer Drug Des; 1994 Oct 01; 9(5):389-99. PubMed ID: 7945723
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
    Zhai X, Beckmann H, Jantzen HM, Essigmann JM.
    Biochemistry; 1998 Nov 17; 37(46):16307-15. PubMed ID: 9819223
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
    Gibbons GR, Wyrick S, Chaney SG.
    Cancer Res; 1989 Mar 15; 49(6):1402-7. PubMed ID: 2924297
    [Abstract] [Full Text] [Related]

  • 18. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
    Sundquist WI, Lippard SJ, Stollar BD.
    Proc Natl Acad Sci U S A; 1987 Dec 01; 84(23):8225-9. PubMed ID: 2446320
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC, Barnes D, Erickson LC.
    Cancer Res; 1985 Sep 01; 45(9):4043-7. PubMed ID: 3896476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.